TrialCancer chemotherapy and pharmacology2023

External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data.

Nastya Kassir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.